Most Recent
A patient who gave his plastic surgeon a one-star review for a nose job is challenging a judgment that put him on the hook for $50,000 in defamation damages.
A class action against Volkswagen over allegedly deadly Takata airbags has failed a second time after an appeals court found “a merely speculative” risk of rupture was not enough to find the vehicles unacceptable.
A top orthopaedic surgeon and former NSW Australian of the year has argued in his defamation case against Nine that stories detailing his alleged negligence misled the public about medical issues and were the “opposite of public interest” journalism.
On the first day of a seven-week trial, the applicant in a class action against Monsanto has taken aim at the agrochemical giant’s “same old approach” to undermining decades of evidence it says demonstrates the cancer-causing properties of popular weed killer Roundup.
Fintech Tyro has taken an authorised representative to court for allegedly breaching its contractual obligations by pushing a competing payment system on merchants.
Agrochemical giant Monsanto is digging in for a fight in a class action over its alleged carcinogenic weed killer, Roundup, having refused to budge in mediation despite a $16 billion settlement in the US.
Westpac has settled its claims against the father of Forum Finance director Vince Tesoriero, who along with fellow director Bill Papas is accused of perpetrating a $400 million fraud against the bank to fund their lavish lifestyles.
A paparazzo suing Seven for defamation over an interview with Meghan Markle’s father has failed to strike out the broadcaster’s contextual truth defence alleging he is a conman that sought to portray victims of Harvey Weinstein in a bad light.
A 16-year battle between the federal government and drug maker Sanofi-Aventis over an allegedly unjustified court order that prevented the release of a generic version of blockbuster blood-thinner Plavix has gone to the High Court.
A judge has endorsed Medibank’s bid to sue the OAIC so the court can weigh in on the health insurer’s bid to halt the regulator's investigation in favour of a class action over its October data breach, saying the OAIC's interference with the court proceedings could constitute a contempt of court.